ETFs
V
VTRS
Viatris Inc Ord Shs
14.82
-0.06-0.37%Opening09:52 04/21 EDT
OPEN/PREV CLOSE14.82/14.87
TODAY RANGE14.69-14.86
VOL480.47K
MARKET CAP17.25B
52 WEEK RANGE7.13-16.33
AVG VOL (3M)10.16M
% TURNOVER0.04%
TURNOVER--
P/E (TTM)-4.9344
% RANGE1.14%
EPS(TTM)-3.0024
P/E(FORWARD)63.72
P/B1.159
BVPS12.78
DIVIDEND0.4800
P/S1.193
BETA--
DIV YIELD3.24%
FREE FLOAT MKT CAP17.18B
SHARES OUTSTANDING1.16B
NEXT EARNINGS05/06-05/11
FREE FLOAT1.16B
LOT SIZE1
EX-DATE03/09/2026
News
Press Releases
Financial Reports
Profile
Seeking Alpha·2d ago
Notable healthcare headlines for the week: J&J, Abbott and Organon in focus
Dow Jones·3d ago
Viatris Inc. Stock Advances 4.8%, Outperforms Market
MarketWatch·3d ago
Viatris Inc. stock rises Friday, outperforms market
The Motley Fool·4d ago
QSM Asset Management Loads Up 611,000 Mobileye Shares
Seeking Alpha·4d ago
The 10 Healthcare stocks with the lowest forward P/E ratios
Benzinga·4d ago
FDA Takes Step Forward on Testosterone Therapy for Men
Benzinga·6d ago
Wall Street's Most Accurate Analysts Weigh In On 3 Health Care Stocks With Over 3% Dividend Yields
Simply Wall St·6d ago
Viatris Ophthalmology Data At ASCRS Puts Valuation And Dividend In Focus
Seeking Alpha·04/14 09:50
Quant check on David Einhorn's Greenlight Capital holdings post Q1
Reuters·04/13 19:18
Teva must face Mylan lawsuit over generic competition for Copaxone
PUBT·04/13 10:59
Viatris to report first-quarter results, host webcast call
PR Newswire·04/13 10:59
Viatris to Report First Quarter 2026 Financial Results on May 7, 2026
TipRanks·04/13 09:17
Barclays Keeps Their Buy Rating on Viatris (VTRS)
Simply Wall St·04/11 15:16
Assessing Viatris (VTRS) Valuation After A Recent Share Price Pullback
Reuters·04/10 10:59
Viatris to present Phase 3 MR-141 presbyopia trial data at ASCRS meeting
Same Industry
Name/Symbol
Change%
Price